thalidomide has been researched along with Rheumatism in 8 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, P | 1 |
| Goyal, A | 1 |
| Cusick, A | 1 |
| Aslam, F | 1 |
| Kehl, AS | 1 |
| Corr, M | 1 |
| Weisman, MH | 1 |
| Duzova, A | 1 |
| Bakkaloglu, A | 1 |
| Pasero, G | 1 |
| Marson, P | 1 |
| Gordon, JN | 1 |
| Goggin, PM | 1 |
| Franks, ME | 1 |
| Macpherson, GR | 1 |
| Figg, WD | 1 |
| Lehman, TJ | 1 |
| Wendling, D | 1 |
| Toussirot, E | 1 |
| Michel, F | 1 |
5 reviews available for thalidomide and Rheumatism
| Article | Year |
|---|---|
Review: Enthesitis: New Insights Into Pathogenesis, Diagnostic Modalities, and Treatment.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Autoimmunity; Bone Morphogen | 2016 |
Central nervous system involvement in pediatric rheumatic diseases: current concepts in treatment.
Topics: Anticonvulsants; Central Nervous System Diseases; Child; Cyclophosphamide; Drug Therapy, Combination | 2008 |
Thalidomide and its derivatives: emerging from the wilderness.
Topics: Adjuvants, Immunologic; Cachexia; Crohn Disease; Graft vs Host Disease; Hematologic Neoplasms; Human | 2003 |
Thalidomide.
Topics: Clinical Trials as Topic; Gastrointestinal Diseases; HIV Infections; Humans; Neoplasms; Rheumatic Di | 2004 |
Thalidomide: a comeback?
Topics: Contraindications; Humans; Immunosuppressive Agents; Rheumatic Diseases; Rheumatology; Thalidomide | 2000 |
3 other studies available for thalidomide and Rheumatism
| Article | Year |
|---|---|
Use of Apremilast in Patients With Psoriatic Arthritis During the COVID-19 Pandemic: Comment on the Article by Mikuls et al.
Topics: Adult; Arthritis, Psoriatic; COVID-19; Humans; Pandemics; Rheumatic Diseases; Rheumatology; SARS-CoV | 2021 |
A short story of anti-rheumatic therapy. VIII. The immunodepressants.
Topics: Alkylating Agents; Allergy and Immunology; Antimetabolites; Antirheumatic Agents; Cyclosporine; Foli | 2012 |
Thalidomide for rheumatic disease: the best of both worlds?
Topics: Humans; Immunosuppressive Agents; Rheumatic Diseases; Thalidomide | 2007 |